Using principles from applied game theory, options traders may have an intriguing opportunity with TEVA stock.

TEVA stock jumps 21.6% in three months on branded drug growth, biosimilar launches, and margin-boosting cost cuts.

Teva Pharmaceutical Industries will release its Q2 2025 financial results on July 30, 2025, with a conference call following.

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the most promising stocks according to Wall Street analysts.

According to Benzinga Pro, Teva Pharmaceutical Indus's peer group average for short interest as a percentage of float is 3.59 ...

The rising occurrence of dysmenorrhea, along with greater awareness and advancements in diagnosis, is driving substantial growth in the dysmenorrhea ...

Review the current Teva Pharmaceutical Industries Ltd ADR (TEVA:XNYS) growth, profitability and efficiency, financial health, and cash flow key metrics to decide if TEVA is the best investment for ...

President Trump is readying plans for industry-specific tariffs to kick in alongside his country-by-country duties in two ...

Stay up to date on Teva Pharmaceutical Indus analyst ratings. About Teva Pharmaceutical Indus Teva Pharmaceutical Industries, based in Israel, is the leading generic drug manufacturer in the world.

Duquesne Family Office's billionaire chief dumped his fund's stake in Wall Street's artificial intelligence (AI) darling in ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the most promising stocks according to Wall Street analysts. On June 16, Teva Pharmaceutical announced a collaboration agreement with ...